Preimplantation Genetic Testing (PGT) represents a revolutionary approach in reproductive medicine, enabling the examination and diagnosis of embryos before implantation into the uterus. Indications for PGT encompass a wide range of genetic conditions, from chromosomal abnormalities to single gene disorders, providing prospective parents with the opportunity to make informed decisions about their future child. However, the process of PGT is not without challenges, as it involves complex procedures and raises ethical and moral dilemmas. The advantages of PGT are evident in its ability to prevent the transmission of hereditary diseases and reduce the likelihood of miscarriages and potential IVF cycle failures. Nonetheless, the possibility of misdiagnosis and the high cost of the procedure underscore the need for further research and refinement. Legal frameworks and regulations related to PGT vary, highlighting the need for standardization and greater accessibility. While some countries have strict regulations governing the use of PGT, others adopt a more liberal policy, raising questions about the ethical aspect and autonomy of embryos. From an economic perspective, the cost of the procedure varies depending on the center where it is performed, making the IVF procedure more expensive and inaccessible for some couples. Since PGT is still a relatively new diagnostic method, there is room for its advancement, which should focus on addressing the current limitations of PGT, including the development of more precise and less invasive testing methods. This progress should lead to improved pregnancy outcomes and increased availability of genetic testing. Ethical issues are crucial for a comprehensive consideration of PGT, primarily concerning the question of the dignity of embryos. Therefore, while PGT offers significant achievements in reproductive medicine, its widespread acceptance requires careful consideration of ethical, legal, and social aspects. By overcoming these challenges and promoting interdisciplinary collaboration, PGT has revolutionary potential in assisted reproduction, while preserving ethical standards and patient welfare.